Health & Wellness
10/04/2026 · Eclectic
Voters Seek Clear Policy Details, Economic Security from Candidates
Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.
Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial
Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.
10/01/2026
Social Anxiety: Identifying and Modifying Contributing Behaviors
Social anxiety affects a significant portion of the population. Experts identify specific behaviors, often developed as coping mechanisms, that can inadvertently intensify symptoms. Understanding and altering these habits may improve an individual's experience.
10/01/2026
Dementia Patient Medication Use: A Michigan Case Study
A Michigan woman's case highlights family and guardian choices concerning sedating medications for agitated dementia patients. These medications are used in long-term care facilities. Federal initiatives aim to reduce their application.
09/30/2026
HHS Report on Gender-Affirming Care Draws Scrutiny
A recent report from a federal health agency is prompting discussion regarding established healthcare models for transgender individuals. Critics characterize the report's framing of transgender identity in specific ways.
09/30/2026
Eli Lilly Drug Retatrutide Shows Weight Loss in Type 2 Diabetes Trial
Eli Lilly's experimental drug retatrutide led to notable weight reduction in individuals with Type 2 diabetes, according to new trial results. Participants in the study, published in The Lancet, experienced an average loss of up to 60 pounds.
09/30/2026
Advertisement
Upcoming Events
View allOCT
03
Lane at Miles
19:00
OCT
03
Samford at UAB
19:30
OCT
03
Alabama St. at Bethune-Cookman
20:00
Announcements
View allPublic Hearing Announced for New Regulations by AG's Office
NOTICE IS HEREBY GIVEN that the Alabama Attorney General's office will hold a public hearing concerning proposed regulations pertaining to [specific area of regulation, if mentioned in original content]. The hearing is scheduled for [Date] at [Time] in the [Location/Room Number] at the Attorney General's office, [Address]. Written comments will also be accepted until [Date]. Further details and the full text of the proposed regulations are available on our website.
Alabama AG Website Sitemap Available
This is the sitemap for the Alabama Attorney General's website. It contains links to various pages and resources for users to access information. The sitemap is organized into multiple parts for better navigation.
Unknown City Council to Hold Public Hearing on Zoning Amendments Next Tuesday
NOTICE IS HEREBY GIVEN that the City Council of Unknown will conduct a public hearing on the following matter: Proposed amendments to the Unknown Zoning Ordinance, Section 4.1, regarding commercial property setbacks. The hearing will take place on Tuesday, October 27, 2023, at 7:00 PM in the City Council Chambers, located at 123 Main Street, Unknown, AL 35XXX. All interested parties are invited to attend and present their views. Written comments may be submitted to the City Clerk prior to the hearing.
Advertisement
Advertisement